ParkerVision Reports Second Quarter 2025 Results
ParkerVision (OTCQB:PRKR) reported Q2 2025 financial results with a net loss of $1.6 million ($0.01 per share), compared to a $0.3 million loss in Q2 2024. The company ended the quarter with $2.05 million in cash. Operating expenses increased 69% due to a $2.5 million one-time non-cash charge related to share option modifications.
In legal developments, ParkerVision faces challenges in its Qualcomm case after an unfavorable claim construction ruling, which the company plans to appeal. Two patent infringement trials are scheduled for Q1 2026 in Texas against Realtek (January) and MediaTek (March). The PTAB denied two IPR petitions filed by Realtek, while cases against Texas Instruments and NXP remain stayed pending PTAB decisions expected in November 2025.
ParkerVision (OTCQB:PRKR) ha comunicato i risultati finanziari del Q2 2025 con una perdita netta di $1,6 milioni ($0,01 per azione), rispetto a una perdita di $0,3 milioni nel Q2 2024. La società ha chiuso il trimestre con $2,05 milioni in cassa. Le spese operative sono aumentate del 69% a causa di un addebito non monetario una tantum di $2,5 milioni legato alla modifica delle opzioni azionarie.
Sul fronte legale, ParkerVision incontra difficoltà nella causa contro Qualcomm dopo una decisione sfavorevole sull'interpretazione delle rivendicazioni, decisione che la società intende impugnare. Sono fissati due processi per violazione di brevetto nel primo trimestre 2026 in Texas contro Realtek (gennaio) e MediaTek (marzo). Il PTAB ha respinto due petizioni IPR presentate da Realtek, mentre i procedimenti contro Texas Instruments e NXP restano sospesi in attesa delle decisioni del PTAB previste per novembre 2025.
ParkerVision (OTCQB:PRKR) informó resultados financieros del Q2 2025 con una pérdida neta de $1,6 millones ($0,01 por acción), frente a una pérdida de $0,3 millones en el Q2 2024. La compañía terminó el trimestre con $2,05 millones en efectivo. Los gastos operativos aumentaron un 69% debido a un cargo no monetario único de $2,5 millones relacionado con modificaciones en las opciones sobre acciones.
En cuanto a asuntos legales, ParkerVision afronta problemas en su caso contra Qualcomm tras una resolución desfavorable sobre la construcción de las reivindicaciones, resolución que la empresa planea apelar. Están programados dos juicios por infracción de patentes en el primer trimestre de 2026 en Texas contra Realtek (enero) y MediaTek (marzo). El PTAB negó dos peticiones IPR presentadas por Realtek, mientras que los casos contra Texas Instruments y NXP permanecen en espera hasta que el PTAB emita decisiones previstas para noviembre de 2025.
ParkerVision (OTCQB:PRKR)는 2025년 2분기 실적을 발표하며 $1.6 million(주당 $0.01)의 순손실을 기록했습니다. 이는 2024년 2분기의 $0.3 million 손실과 비교됩니다. 분기 말 현금 잔액은 $2.05 million이었습니다. 영업비용은 주식옵션 수정과 관련된 $2.5 million의 일회성 비현금성 비용으로 인해 69% 증가했습니다.
법적 측면에서는, ParkerVision이 Qualcomm 사건에서 청구항 해석(claim construction)에 불리한 판결을 받은 후 어려움에 직면해 있으며, 회사는 이에 대해 항소할 계획입니다. 텍사스에서 Realtek(1월)과 MediaTek(3월)을 상대로 2026년 1분기에 두 건의 특허침해 재판이 예정되어 있습니다. PTAB는 Realtek가 제기한 두 건의 IPR 청원을 기각했으며, Texas Instruments 및 NXP를 상대로 한 사건들은 PTAB의 2025년 11월 결정이 나올 때까지 계류 중입니다.
ParkerVision (OTCQB:PRKR) a publié ses résultats du T2 2025 affichant une perte nette de 1,6 M$ (0,01 $ par action), contre une perte de 0,3 M$ au T2 2024. La société a clôturé le trimestre avec 2,05 M$ de trésorerie. Les charges d'exploitation ont augmenté de 69 % en raison d'une charge non monétaire exceptionnelle de 2,5 M$ liée à des modifications des options d'achat d'actions.
Sur le plan juridique, ParkerVision fait face à des difficultés dans son affaire contre Qualcomm après une décision défavorable sur la construction des revendications, décision dont la société prévoit de faire appel. Deux procès pour contrefaçon de brevets sont programmés pour le premier trimestre 2026 au Texas contre Realtek (janvier) et MediaTek (mars). Le PTAB a rejeté deux requêtes IPR déposées par Realtek, tandis que les dossiers contre Texas Instruments et NXP restent en suspens en attendant les décisions du PTAB prévues pour novembre 2025.
ParkerVision (OTCQB:PRKR) meldete die Finanzergebnisse für Q2 2025 mit einem Nettoverlust von $1,6 Millionen ($0,01 je Aktie), verglichen mit einem Verlust von $0,3 Millionen im Q2 2024. Das Unternehmen schloss das Quartal mit $2,05 Millionen an liquiden Mitteln. Die Betriebskosten stiegen um 69% aufgrund einer einmaligen nicht zahlungswirksamen Belastung von $2,5 Millionen im Zusammenhang mit Änderungen an Aktienoptionen.
In rechtlicher Hinsicht steht ParkerVision in der Auseinandersetzung mit Qualcomm nach einer ungünstigen Auslegung der Patentansprüche vor Herausforderungen, gegen die das Unternehmen Berufung einlegen will. Zwei Patentverletzungsprozesse sind für das erste Quartal 2026 in Texas angesetzt, gegen Realtek (Januar) und MediaTek (März). Das PTAB wies zwei von Realtek eingereichte IPR-Petitionen zurück, während die Verfahren gegen Texas Instruments und NXP bis zu den vom PTAB erwarteten Entscheidungen im November 2025 ausgesetzt bleiben.
- PTAB denied two IPR petitions filed by Realtek, preserving patent claims
- Two major patent infringement trials scheduled for Q1 2026
- Gain of $2.3M recognized from changes in contingent payment obligations in Q2
- Net loss increased to $1.6M in Q2 2025 from $0.3M in Q2 2024
- Operating expenses increased 69% year-over-year
- Cash position decreased to $2.05M from $4.92M at year-end 2024
- Unfavorable claim construction ruling in Qualcomm case
- Multiple patent cases stayed pending PTAB decisions
JACKSONVILLE, FL / ACCESS Newswire / August 12, 2025 / ParkerVision, Inc. (OTCQB:PRKR) ("ParkerVision" or the "Company"), a developer and marketer of technologies and products for wireless applications, today announced results for the three and six months ended June 30, 2025.
2025 Summary and Recent Developments
|
The Company also has a pending request for the court to reconsider its denial of a motion to replace ParkerVision's technical expert who is medically unable to continue. |
The court has not yet ruled on these outstanding motions. |
|
|
|
Jeffrey Parker, CEO of ParkerVision, commented, "It has been almost two months since we filed our request with the Orlando district court to issue a final judgement on our receiver claims in the Qualcomm case in order to allow us to appeal the court's May 30th claim construction ruling. We remain hopeful that the court will rule in our favor. This court has commented on the challenges of efficiency in patent cases, and this will provide a path to what we believe to be the most efficient and expeditious resolution of this long-standing case. Meanwhile, we continue to focus on our Texas actions, including the Realtek case, which is scheduled for trial in five months, and IPR defenses to preserve our patent claims in other cases."
Mr. Parker continued, "ParkerVision continues working to raise awareness of the essential role innovators play in driving technological leadership and national security for the United States. We have intellectual property assets that are yet untapped that we believe can bring significant benefits to burgeoning advanced wireless applications such as 5G, but we also firmly believe that a solid U.S. patent protection system is crucial in order to justify the continuation of investment in innovation."
Financial Results
ParkerVision reported a net loss for the second quarter of 2025 of
$1.6 million , or$0.01 per common share, compared to a net loss of$0.3 million , or$0.00 per common share for the second quarter of 2024. On a year-to-date basis, the Company reported a net loss for the first six months of 2025 of$5.4 million , or$0.05 per common share, compared to a net loss of$1.0 million , or$0.01 per common share for the same period in 2024.The increase in net loss for the three months ended June 30, 2025, when compared to the three months ended June 30, 2024, is primarily the result of a
$3.2 million increase in operating expenses, offset by a$1.8 million increase in the gain recognized from decreases in the estimated fair value of the Company's contingent payment obligations.The increase in net loss for the six months ended June 30, 2025, when compared to the six months ended June 30, 2024, is primarily the result of a
$3.6 million increase in operating expenses along with a$0.9 million change in the estimated fair value of the Company's contingent payment obligations.Increases in operating expenses of
69% and78% , respectively, for the three and six months ended June 30, 2025, were the result of a$2.5 million one-time, non-cash charge to share-based compensation expense recognized on the modification of nonqualified share options. The modification extended the expiration date of options held by executives and other employees from January 2026 to January 2031. All other terms of the options, including the$0.54 exercise price per share, remain unchanged. In addition to non-cash expenses, the Company had increases in operating expenses attributable to the costs for consulting, litigation, and public relations services for the three and six months ended June 30, 2025.The gains and losses recognized on changes in the fair value of the Company's contingent payment obligations result from changes in estimated amounts and timing of projected future cash flows for the repayment of the Company's contingent payment obligations. The assumptions used in these estimates are highly subjective and may not be reflective of amounts actually repaid in the future which are contingent upon receipt of proceeds from patent enforcement, licensing and other patent-related items.
The Company used approximately
$3.0 million in cash for operations for the first six months of 2025 and ended the quarter with$2.05 million in cash and cash equivalents.
About ParkerVision
ParkerVision, Inc. invents, develops and licenses cutting-edge, proprietary radio-frequency (RF) technologies that enable wireless solution providers to make and sell advanced wireless communication products. ParkerVision is engaged in a number of patent enforcement actions in the U.S. to protect patented rights that it believes are broadly infringed by others. For more information, please visit www.parkervision.com. (PRKR-I)
Safe Harbor Statement
This press release contains "forward-looking statements" within the meaning of the Private Securities Litigation Reform Act of 1995. These include statements regarding the timing, scheduling, and expected outcomes of current and future legal proceedings; the potential impact and significance of such proceedings; and expectations concerning court and PTAB rulings, trial dates, and pre-trial motions. Forward-looking statements also include estimates and assumptions underlying financial information, including the fair value of contingent payment obligations and the Company's ability to support ongoing operations and litigation.
These statements are based on current expectations, estimates, projections, and assumptions as of the date of this release, and involve known and unknown risks and uncertainties that could cause actual results to differ materially. Words such as "believe," "hopeful," "will," and similar expressions are intended to identify forward-looking statements, though not all forward-looking statements include these words. Risks and uncertainties that may cause actual results to differ include, among others: adverse developments or delays in legal proceedings; unfavorable court or PTAB decisions or rulings; the loss or unavailability of key expert witnesses; the availability of funding for continued operations and litigation; changes in the legal or regulatory environment; inaccuracies in financial estimates or assumptions; and risks disclosed in the Company's filings with the Securities and Exchange Commission, including its Annual Report on Form 10-K for the year ended December 31, 2024, and subsequent filings.
Readers are cautioned not to place undue reliance on forward-looking statements, which speak only as of the date made. Except as required by law, the Company undertakes no obligation to update or revise any forward-looking statements to reflect subsequent events or circumstances.
Cindy French
Chief Financial Officer
ParkerVision, Inc.
cfrench@parkervision.com
(TABLES FOLLOW)
ParkerVision, Inc.
Balance Sheet Highlights (unaudited)
(unaudited) | ||||||||
(in thousands) | June 30, 2025 | December 31, 2024 | ||||||
Cash and cash equivalents | $ | 2,048 | $ | 4,918 | ||||
Prepaid expenses and other current assets | 252 | 127 | ||||||
Intangible assets & other noncurrent assets | 771 | 834 | ||||||
Total assets | 3,071 | 5,879 | ||||||
Current liabilities | 2,457 | 2,408 | ||||||
Contingent payment obligations | 46,816 | 46,659 | ||||||
Convertible notes, net of current portion | 2,008 | 3,023 | ||||||
Other long-term liabilities | 130 | 201 | ||||||
Shareholders' deficit | (48,340 | ) | (46,412 | ) | ||||
Total liabilities and shareholders' deficit | $ | 3,071 | $ | 5,879 | ||||
ParkerVision, Inc.
Summary Results of Operations(unaudited)
Three Months Ended | Six Months Ended | |||||||||||||||
(in thousands, except per share amounts) | June 30, | June 30, | ||||||||||||||
2025 | 2024 | 2025 | 2024 | |||||||||||||
Licensing revenue | $ | - | $ | - | $ | - | $ | - | ||||||||
Cost of sales | (51 | ) | (58 | ) | (106 | ) | (117 | ) | ||||||||
Gross margin | (51 | ) | (58 | ) | (106 | ) | (117 | ) | ||||||||
Selling, general and administrative expenses | 3,843 | 683 | 5,086 | 1,457 | ||||||||||||
Total operating expenses | 3,843 | 683 | 5,086 | 1,457 | ||||||||||||
Interest expense and other | (44 | ) | (88 | ) | (84 | ) | (168 | ) | ||||||||
Change in fair value of contingent payment obligations | 2,304 | 502 | (157 | ) | 722 | |||||||||||
Total other income (expense) | 2,260 | 414 | (241 | ) | 554 | |||||||||||
Net loss | $ | (1,634 | ) | $ | (327 | ) | $ | (5,433 | ) | $ | (1,020 | ) | ||||
Basic and diluted net loss per common share | $ | (0.01 | ) | 0.00 | $ | (0.05 | ) | $ | (0.01 | ) | ||||||
Weighted average shares outstanding | 118,797 | 88,683 | 117,322 | 88,424 | ||||||||||||
ParkerVision, Inc.
Summary of Cash Flows
(unaudited)
Six Months Ended | ||||||||
(in thousands) | June 30, | |||||||
2025 | 2024 | |||||||
Net cash used in operating activities | $ | (2,969 | ) | $ | (1,418 | ) | ||
Net cash used in investing activities | (43 | ) | - | |||||
Net cash provided by (used in) financing activities | 142 | (117 | ) | |||||
Net decrease in cash and cash equivalents | (2,870 | ) | (1,535 | ) | ||||
Cash and cash equivalents - beginning of period | 4,918 | 2,560 | ||||||
Cash and cash equivalents - end of period | $ | 2,048 | $ | 1,025 | ||||
SOURCE: ParkerVision, Inc.
View the original press release on ACCESS Newswire
FAQ
What were ParkerVision's (PRKR) Q2 2025 financial results?
What is the status of ParkerVision's patent litigation against Qualcomm?
When are ParkerVision's next scheduled patent infringement trials?
Why did ParkerVision's operating expenses increase in Q2 2025?
What was the outcome of Realtek's IPR petitions against ParkerVision?
